Erlotinib Completed Phase 2 Trials for Fallopian Tube Cancer / Peritoneal Cavity Cancer / Ovarian Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00030446Erlotinib and Carboplatin in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer